Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NHC
NHC logo

NHC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy National Healthcare Corp (NHC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
195.960
1 Day change
-0.02%
52 Week Range
205.060
Analysis Updated At
2026/05/22
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

NHC is not a strong buy right now for a beginner long-term investor, even with $50,000-$100,000 available. The technical setup is constructive, but the lack of news catalysts, no strong proprietary buy signal, neutral insider/hedge fund activity, and limited financial/valuation visibility make this more of a hold than an immediate buy. If the investor is impatient and wants to act now, the current setup is acceptable for a small starter position, but not a clear full-position buy.

Technical Analysis

Technically, NHC is in a bullish short-term trend: SMA_5 > SMA_20 > SMA_200, which confirms positive structure. The MACD histogram is above zero at 1.28, though it is contracting, suggesting momentum is still positive but cooling. RSI_6 at 63.535 is neutral-to-mildly bullish and not overextended. Price at 196 is above the pivot of 191.259 and below first resistance at 202.933, so the stock is trading near the upper part of its current range with room to test resistance. Overall trend is positive, but not strong enough to call it a fresh high-conviction entry.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Options sentiment is bullish from open interest, with a low put-call ratio of 0.29. However, the volume put-call ratio of 3.0 shows heavier put activity today, which tempers the optimism and suggests some near-term hedging or caution. Implied volatility at 23.14 is relatively modest, with low IV percentile (8.33) and IV rank (2.68), indicating options are not pricing in a major event premium. Overall, options data is mixed-to-bullish, but not a clean breakout signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
1
Buy
8

Positive Catalysts

  • implies bullish positioning", "No negative news in the recent week", "Pre-market price remains above the pivot level"]

Neutral/Negative Catalysts

  • ["No news catalysts in the recent week", "AI Stock Picker shows no signal today", "SwingMax shows no recent signal", "Insiders are neutral with no significant recent buying", "Hedge funds are neutral with no significant recent trading trend", "Financial snapshot unavailable, limiting fundamental confirmation", "Comparable-pattern trend estimate suggests weakness over the next month"]

Financial Performance

Financial data is not available due to an error in the snapshot, so the latest quarter season and growth trends cannot be confirmed. Because of that, there is no evidence here to support a strong fundamental buy case.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no visible Wall Street upgrade momentum. Based on the absence of analyst support, the Wall Street view appears neutral rather than strongly bullish.

Wall Street analysts forecast NHC stock price to rise
Analyst Rating
0
Wall Street analysts forecast NHC stock price to rise
Buy
Hold
Sell
0
Current: 196.000
sliders
Low
0
Averages
0
High
0
0
Current: 196.000
sliders
Low
0
Averages
0
High
0
Truist
Hold
maintain
$76 -> $77
AI Analysis
2025-06-09
Reason
Truist
Price Target
$76 -> $77
AI Analysis
2025-06-09
maintain
Hold
Reason
Truist raised the firm's price target on National Health Investors (NHI) to $77 from $76 and keeps a Hold rating on the shares as part of a broader research note updating the firm's estimates on Healthcare REITs. Truist is expecting the National Healthcare Corporation (NHC) lease to ultimately be renewed at a 10%-15% higher rental rate, even though the outcome of renewal remains uncertain, the analyst tells investors in a research note.

People Also Watch